JP2010507096A5 - - Google Patents

Download PDF

Info

Publication number
JP2010507096A5
JP2010507096A5 JP2009533355A JP2009533355A JP2010507096A5 JP 2010507096 A5 JP2010507096 A5 JP 2010507096A5 JP 2009533355 A JP2009533355 A JP 2009533355A JP 2009533355 A JP2009533355 A JP 2009533355A JP 2010507096 A5 JP2010507096 A5 JP 2010507096A5
Authority
JP
Japan
Prior art keywords
disease
iap
methylamino
cyclohexyl
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009533355A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010507096A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/022125 external-priority patent/WO2008057172A2/en
Publication of JP2010507096A publication Critical patent/JP2010507096A/ja
Publication of JP2010507096A5 publication Critical patent/JP2010507096A5/ja
Pending legal-status Critical Current

Links

JP2009533355A 2006-10-19 2007-10-17 有機化合物 Pending JP2010507096A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86216106P 2006-10-19 2006-10-19
US86215506P 2006-10-19 2006-10-19
PCT/US2007/022125 WO2008057172A2 (en) 2006-10-19 2007-10-17 Organic compounds

Publications (2)

Publication Number Publication Date
JP2010507096A JP2010507096A (ja) 2010-03-04
JP2010507096A5 true JP2010507096A5 (https=) 2010-11-25

Family

ID=39364966

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009533355A Pending JP2010507096A (ja) 2006-10-19 2007-10-17 有機化合物

Country Status (10)

Country Link
US (1) US20100316573A1 (https=)
EP (1) EP2076778A2 (https=)
JP (1) JP2010507096A (https=)
KR (1) KR20090082221A (https=)
AU (1) AU2007318220A1 (https=)
BR (1) BRPI0717411A2 (https=)
CA (1) CA2665838A1 (https=)
MX (1) MX2009004061A (https=)
RU (1) RU2009118487A (https=)
WO (1) WO2008057172A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2475207T3 (es) 2004-07-15 2014-07-10 Tetralogic Pharmaceuticals Corporation Compuestos de unión a IAP
MX2007010371A (es) 2005-02-25 2008-01-11 Tetralogic Pharmaceuticals Inhibidores dimericos iap.
JP4954983B2 (ja) 2005-05-18 2012-06-20 ファーマサイエンス・インコーポレイテッド Birドメイン結合化合物
WO2007048224A1 (en) 2005-10-25 2007-05-03 Aegera Therapeutics Inc. Iap bir domain binding compounds
KR20080080131A (ko) 2005-12-20 2008-09-02 노파르티스 아게 Iap-억제제와 탁산의 조합물
TWI504597B (zh) 2006-03-16 2015-10-21 Pharmascience Inc 結合於細胞凋亡抑制蛋白(iap)之桿狀病毒iap重複序列(bir)區域之化合物
CN101535300B (zh) 2006-05-16 2014-05-28 埃格拉医疗公司 Iap bir域结合化合物
MX2009000824A (es) 2006-07-24 2009-02-04 Tetralogic Pharmaceuticals Cor Antagonistas dimericos de las proteinas inhibidoras de la apoptosis.
US20100056495A1 (en) * 2006-07-24 2010-03-04 Tetralogic Pharmaceuticals Corporation Dimeric iap inhibitors
JP5452223B2 (ja) 2006-07-24 2014-03-26 テトラロジック ファーマシューティカルズ コーポレーション Iap阻害剤
JP2010528587A (ja) * 2007-05-07 2010-08-26 テトラロジック ファーマシューティカルズ コーポレーション アポトーシス阻害タンパク質のアンタゴニストに対する感受性のバイオマーカーとしてTNFα遺伝子の発現を用いる方法
CN102099035A (zh) * 2008-05-16 2011-06-15 诺瓦提斯公司 Iap抑制剂的免疫调节
US8283372B2 (en) 2009-07-02 2012-10-09 Tetralogic Pharmaceuticals Corp. 2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
EP2478358A1 (en) * 2009-09-18 2012-07-25 Novartis AG Biomarkers for iap inhibitor compounds
US9284350B2 (en) 2010-02-12 2016-03-15 Pharmascience Inc. IAP BIR domain binding compounds
UY33236A (es) * 2010-02-25 2011-09-30 Novartis Ag Inhibidores dimericos de las iap
UY33794A (es) 2010-12-13 2012-07-31 Novartis Ag Inhibidores diméricos de las iap
US9353419B2 (en) 2012-05-04 2016-05-31 Novartis Ag Biomarkers for IAP inhibitor therapy
GB201305376D0 (en) * 2013-03-25 2013-05-08 Univ Leuven Kath Novel viral replication inhibitors
WO2015109391A1 (en) 2014-01-24 2015-07-30 Children's Hospital Of Eastern Ontario Research Institute Inc. Smc combination therapy for the treatment of cancer
KR102166292B1 (ko) * 2018-11-13 2020-10-15 국민대학교 산학협력단 퀴논계 화합물을 유효성분으로 포함하는 피부 미백용 조성물 및 그 화합물의 스크리닝 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1715882A4 (en) * 2004-01-16 2009-04-08 Univ Michigan SMAC-PEPTIDOMIMETIKA AND ITS USES
DK2253614T3 (da) * 2004-04-07 2013-01-07 Novartis Ag IAP-inhibitorer
PE20110220A1 (es) * 2006-08-02 2011-04-11 Novartis Ag DERIVADOS DE 2-OXO-ETIL-AMINO-PROPIONAMIDA-PIRROLIDIN-2-IL-SUSTITUIDOS COMO INHIBIDORES DEL ENLACE DE LA PROTEINA Smac AL INHIBIDOR DE LA PROTEINA DE APOPTOSIS

Similar Documents

Publication Publication Date Title
JP2010507096A5 (https=)
RU2461551C2 (ru) Азолкарбоксамидное соединение или его фармацевтически приемлемая соль
JP2022531446A5 (https=)
EP1001934B1 (en) Indole compounds as cox-2 inhibitors
JP2010506847A5 (https=)
MX2010004501A (es) Inhibidor de la proteina de activacion de 5-lipoxigenasa (plap).
CO6450624A2 (es) Compuestos vinil indazolilo
WO2008097538A8 (en) Therapeutic agents
JP2002053555A5 (https=)
WO2002051442A1 (en) Concomitant drugs
CY2014032I1 (el) Νεα φαρμακα για τη θεραπεια της χρονιας αποφρακτικης πνευμονοπαθειας
JP2004508357A5 (https=)
JP2012507535A5 (https=)
JP2005517007A (ja) ヒストンデアセチラーゼ阻害剤としての新規二環式ヒドロキサメート
JP2012530705A5 (https=)
NZ598125A (en) Apaf-1 inhibitor compounds
WO2008050101A3 (en) Benzoyl amino heterocyclyl compounds useful in the treatment of a disease mediated through glk
JP2018522581A5 (https=)
NO20044999L (no) Polymorf av 4-[2-[4-[1-(2-etoksyetyl)-1H-benzimidazol-2-yl]-1-piperidinyl]etyl]-alfa,alfa-dimetyl-benzeneddiksyre
MA28394B1 (fr) Derives d'heteroaryle pour traitement des virus
JP2007519717A5 (https=)
JP2008526988A5 (https=)
JP2012520302A5 (https=)
JP2003252854A (ja) アンドロゲン受容体拮抗剤
JP2012522806A (ja) 抗ウイルス処置のためのインドール誘導体および方法